Today the platform meters a shrinking pool of doctor visits, and the reps who pay for it are in open revolt. Sprint 0 rebuilds RxVantage around access that's earned through relevance, shown in plain sight.
Before a single screen is redesigned, we went deep on the product, its users, and its market, to validate our understanding of the space and earn the right to design.
Walked the rep knowledge base, booking engine mechanics, mobile app flows, messaging rules, and the practice-side marketing surface to map how the product actually behaves.
Mined App Store & Google Play reviews, Capterra, G2, Software Advice, GetApp, SoftwareFinder, Cafepharma forums, BBB and Glassdoor for unfiltered feedback from both sides of the marketplace.
Profiled the company, funding, and business model; scanned competitors and adjacent players; pulled industry data on rep access, compliance, and practice staffing.
RxVantage is the system of record for rep visits to medical practices: the scheduling layer between life-science reps and the front desk, coordinating lunches, in-services, and sample drops nationwide.
After absorbing its only direct competitors (RepAccess, RepConnect era), RxVantage effectively is the category. Its real rival is the status quo, the front-desk phone, and its real risk is the loyalty of the side that pays.
Walking the product's own documentation reveals an experience architected around scarcity, deadlines, and throttles, for every actor.
Opening an appointment starts a 2-minute hold timer, "click book now before the timer expires or you could lose it to another rep." Slots release monthly and are gone in minutes.
Confirm only between 14 days and 72 hours before the visit, miss the window and the appointment silently auto-cancels and re-releases. The single largest source of cross-side pain in all our VoC data.
Reps can't initiate messages. One outbound message per confirmed appointment; replies only if the office enables them; deleted threads unrecoverable. Coordination leaks to the phone, off-platform.
Desktop says "My Providers," mobile says "My Docs" (buried under More). Filters reset every session, territory setup is zip-code-brittle, invoices are desktop-only, and forced app updates hit at calendar-open time.
The practice-side rules engine, availability, vetting, rep tracking, blacklisting, multi-location coordination, is loved (4.6/5, 30+ reviews) and must be preserved, not redesigned away.
Four market currents make this redesign more than cosmetic, they decide whether the category itself survives.
Fewer doors are open, each visit costs more and carries more compliance weight, and the people guarding the doors keep changing. A platform that makes every visit easier, fairer, and provably valuable wins both sides. One that merely meters access invites revolt, and digital substitution (Doximity, OptimizeRx, AI agents) is waiting.
Capterra · 67 reviews
"A life-saver" · "Set it and forget it" · "No catch"
Apple App Store · 135 ratings (Google Play: 2.5/5)
"Scam" · "Corrupt and greedy" · "Rx Disadvantage"
The strategic problem: the free practice network is the moat, and the paying reps who fund it are now "organizing around the country" to pull offices off the platform. Rep subscriptions climbed from $75/mo (2018) to a reported $195/mo (2025) while the experience stayed adversarial. Even 5-star practices warn this is "counterproductive to quality patient care."
Each theme is ranked by evidence strength, the count of independent sources. Color shows who feels it.
The moat is under attack from inside. The free practice network creates the lock-in; the paying reps who fund it are campaigning to dismantle it. Rebalancing rep value isn't UX polish, it's existential.
Scarcity is the product, and the poison. Collapsing HCP access makes slots precious; hunger-games allocation (2-minute timers, monthly races, team slot-hoarding) converts that value into resentment instead of revenue.
The visit is bigger than the booking. Catering, attendees, sign-in, compliance reporting, follow-up, RxVantage owns only the calendar slice. The seams (ezCater owns the food, Veeva owns the CRM record) are open whitespace.
Value is invisible, so price is the only conversation. Reps can't see ROI per visit; practices can't see educational value per rep. A marketplace with no value ledger defaults to fighting about rent.
The mission is missing from the experience. "Educational exchanges that improve patient care" is the brand story, but nothing in the UX connects a lunch slot to a provider's patients. Purpose is the untapped differentiator.
When target offices release time, I want a fair shot at the right providers without camping on the app 24/7, so I can plan my territory and keep my evenings.
When a visit is booked, I want food, attendees, materials, parking and check-in handled in one place, so I never burn a relationship over logistics.
When I spend $195/month plus a lunch budget, I want to see who attended, what landed, and what to do next, so I can justify spend and prioritize offices.
When I'm new to a territory or locked out of full calendars, I want a credible path in, virtual-first, content, waitlists, so I'm not waiting a year for a door to open.
When reps want our time, I want rules to vet, schedule and document them automatically, so the front desk never touches the phone. (Today's core strength, preserve.)
When an appointment changes or auto-cancels, I want backfill and notifications handled instantly, so the office never has an empty lunch hour or a double booking.
When providers ask what we got for giving up lunch hours, I want a record of educational value per rep and company, so I can defend or refine our rules.
When I give my lunch hour, I want education matched to my current patients, and the ability to request topics, so the time converts to better care, not just a sandwich.
When a session covers a therapy, I want savings programs and patient materials flowing to my staff automatically, so the visit's value reaches the exam room.
Why this persona matters: the provider–patient loop is where RxVantage's stated mission lives, and it's the loop our prototype closes. Education requested by providers → fulfilled by reps → resources handed to patients.
Mapping the ecosystem exposes where value leaks between players, and where a redesigned RxVantage can own the whole loop.
Booking ↔ catering order ↔ digital sign-in ↔ auto-generated Open Payments record. ezCater stops at the order; RxVantage stops at "preferences." Nobody connects them.
Transparent allocation, waitlists, cancellation refill, pay-per-confirmed-meeting. The 1.4-star backlash is an open invitation, for RxVantage or a challenger.
AcuityMD / Definitive tell reps who to see; RxVantage controls whether they can. Turn target lists into bookable availability with CRM write-back to Veeva / Salesforce.
Who met whom, on what topic, with what follow-up, across companies. The practice-level benchmark layer Veeva Pulse proves pharma will pay for.
Provider-pulled topics, MSL & field-reimbursement sessions, hybrid programs with compliant virtual meals, new inventory beyond the lunch slot.
With 40% front-office turnover, an agent that triages all vendor inbound and enforces practice rules deepens the free-side moat, and defends against generic AI schedulers.
Each concept answers specific jobs and replaces a specific failure of the current experience. Click any card for the detail.
Request windows replace first-click races. Transparent allocation, rotation for new reps, live waitlists that refill cancellations.
Auto-confirm rules, calendar/EMR sync, SMS nudges, a "standby" state instead of silent cancellation.
Every booking becomes a shared workspace: attendees, catering, materials, check-in, sign-in, compliance record, scoped chat.
Providers post the education they want; matched reps and MSLs respond. A virtual-first ladder for locked-out reps.
Per-visit ROI for reps, per-rep value scores for practices, benchmarks for pharma, the foundation for fairer pricing.
One IA and visual language across web, tablet and mobile. Persistent state, modern accessible UI, coherent naming.
Today the product is a gate with a calendar behind it. The Visit Loop reframes it as a continuous exchange of value, demand pulled by providers, access allocated fairly, logistics handled invisibly, and value made visible to everyone who spent time or money.
Not a website, and not two separate demos: one connected prototype you walk end to end, feeling both sides of the Visit Loop at once, the practice on a tablet and the rep on a phone.
A front-desk command center: today's visits, education requests from providers, auto-backfilled cancellations, rep value scores, and a one-glance compliance trail. Calm by default.
A territory copilot: matched opportunities (not a slot race), request-window booking with transparent odds, the Visit Hub for logistics, and a post-visit ROI view worth the subscription. Fair by design.
The 8 moments of the Visit Loop, plus one provider micro-moment (topic request & relevance rating) and one patient handoff (savings program) to close the care loop.
High-fidelity UI on the new Cadence design system, clickable end to end, built to demo in a single 10-minute sitting and to usability-test with real reps and office managers.
That fair allocation feels fair (rep), that automation feels safe (practice), and that the Value Ledger justifies the price (both). These are the bets behind the redesign.
Allocation, transparency, and pricing logic reps can trust. No invisible races, no silent penalties, no pay-to-camp.
You'll see it as: request windows, visible odds, waitlist position, rotation for newcomers, no countdown timers.
Own the whole visit, not the calendar slice. Anything that today leaks to a phone call, a catering app, or a spreadsheet belongs in the loop.
You'll see it as: the Visit Hub, cancellation cascades, integrated catering, auto-compliance records, calendar/EMR sync.
Make education and patient impact visible. The platform's defensible story is better care, design should prove it, not just claim it.
You'll see it as: provider topic requests, relevance ratings, the Value Ledger, patient-savings handoffs.
A calm, clinical-modern language: generous whitespace, a confidence-inspiring palette, persona-aware color coding (practice/rep/provider), evidence-forward data display, replacing the dated, fragmented UI flagged in reviews ("what is this, 2010?"). Full exploration in Phase 3.
We didn't stop at slides. Sprint 0 ships a testable prototype that walks the entire Visit Loop, so you can feel the strategy, not just read it.
The screens ahead are live HTML, embedded from the prototype. Full UX & UI specs accompany this deck.
Same trustworthy DNA, the slate ink, the flowing ribbon, the humanist wordmark, pushed to a real craft level: editorial serif, warm paper, hairline structure, and brass used once where it counts.
The whole Visit Loop, end to end, each card carries its own persona, and the path runs along the top, turns, and folds back: a great visit seeds the next. Click any moment to jump in.
A rep-triggered invite, NPI-prefilled, no download, then a loop that brings her back.
Demand, not a pitch, the loop begins with a real clinical need.
Today's visits, the matched request, a cancellation already auto-backfilled. Nothing needs her.
A ranked feed, then booking with the window, odds and priority reason in plain sight.
Catering, materials, scoped chat, a self-filling compliance record, then one-tap sign-in.
Per-visit ROI for the rep, fed by a 5-second provider relevance pulse.
Savings cards, PA kits and leaflets from the visit flow to staff, the mission, made literal.
A great rating and a follow-up question become the rep's next best moves, back into the loop.
We'll say the quiet part out loud, because it's the right question, and answering it is where this becomes business-model design, not just UX.
It only hurts them if the game is zero-sum.
We're going to make it positive-sum.
Today's "advantage" is a bigger share of a fixed, shrinking pool of lunch slots, and it's exactly what fuels the rep revolt and practice resentment that put the whole network at risk. Trade it for a bigger pie, and everyone, especially enterprise, wins more.
Big pharma keeps every slot it has today. We add new inventory, new revenue lines, and a new market, so total value expands instead of being re-divided.
Capped by a fixed pool of lunch slots. Rep churn is the ceiling; the practice network is the collateral.
Provider-pulled demand + a virtual-first ladder create bookable moments that didn't exist, GMV grows without touching big-pharma volume.
Advantage shifts from hoarding slots to owning the outcomes data, a higher-margin product enterprise will pay more for.
Small manufacturers who churn today become payers at a fair entry point, TAM expansion, not redistribution.
We can't quote your internal numbers yet, so here's the upside framed by cited benchmarks from analogous moves in adjacent markets. Directional, defensible, and ours to validate in Phase 1.
The $3.29B/yr pharma food-&-beverage pool (CMS Open Payments) at a typical 10–20% marketplace take (assumption) is the catering-line opportunity, ezCater's $1.6B valuation proves a business exists purely on corporate-meal intermediation.
The provider & rep adoption we're betting on isn't hoped-for, it's engineered into the product as compounding loops. Each turn makes the next easier.
Rep invites provider at a visit → value-first, no download → better visit → provider trusts, returns & invites colleagues → more demand signal.
Fair access + a Value Ledger → reps succeed → reps advocate to offices → more practices & providers join → more inventory for reps.
Free + calm + proof of value → practices stay & widen their rules → more supply for everyone.
Honest risk: physicians are app-fatigued (80% feel it within ~22 min of EHR use). These loops only spin if every step removes friction, the Doximity lesson, not "another portal."
A roadmap is easy to nod along to. A hypothesis can be proven wrong, which is exactly why we lead with one, and why Sprint 0 already ships a prototype to start testing it.
Reps don't churn because they pay, they churn because they can't see what they're paying for. Make access fair, the visit complete, and value visible, and the 1.4★ revolt turns into advocacy, without weakening the practice-side moat.
Sprint 0 ships a testable happy-path prototype now
Test with reps & office managers; pull internal data
Sharpen JTBD, IA & service blueprint on evidence
Design language & component library at fidelity
Full Visit Loop, both devices, tested again
Specs · measurement plan · build roadmap
Rep app rating & NPS recovery · auto-cancel rate · off-platform booking leakage · time-to-first-booking for new reps · practice retention · % of visits with closed compliance records.
The platform that meters access will be replaced.
The platform that multiplies the value of every visit will be unbeatable.
Every screen in this deck is real and clickable. Open any one below to interact with it directly at true 100% device size, the same pixels a rep or office manager would touch.
RxVantage Rep Knowledge Base (rxvantage.my.site.com): Booking Appointments · Manage Your Target Providers · Mobile App – Manage Your Appointments · Communicating with Your Offices · Mobile App – Manage Your Docs · Getting Started hub
rxvantage.com: homepage, /for-practices/, /for-reps/, Events, Event Boost, Video Conferencing, company & blog pages
Apple App Store (RxVantage for Reps, 1.4★/135) · Google Play (2.5★/53) · Capterra (4.6★/67) · Software Advice · GetApp · G2 · SoftwareFinder · ITQlick · Cafepharma "RxVantage Scam" thread · BBB profile · Glassdoor employee reviews · appstor.io historical snapshot
Veeva Pulse 2024 (HCP access 60→45%) · ZS AccessMonitor via PMLiVE (49% vs 23%) · CMS Open Payments PY2023 ($3.29B, F&B +16%) · MGMA staffing studies 2022–24 · Spectrum Equity, Crunchbase, CB Insights, Tracxn · symplr/IntelliCentrics, Veeva, Salesforce LSC, AcuityMD, ezCater, Badger Maps, Definitive Healthcare
Retention→profit: Bain/Reichheld via HBR 2014. Engagement lift: Veeva Pulse Nov 2024 (rep+digital +30% Rx; 65% unsynchronized). NRR: Bessemer / SaaS Capital / OpenView (usage-based ~+10 pts). PLG & virality: OpenView 2022; Calendly via OpenView. Provider adoption: Doximity 2025 (80%+), ZocDoc; tech-fatigue counter-evidence: NCBI/PMC, AMA, JMIR 2023. Marketplace rebalancing: OpenTable (Harvard d3), Airbnb Superhost (+64%), a16z GMV retention. Catering: ezCater / Business Wire; CMS Open Payments. App rating→conversion: AppTweak ASO. All value figures are benchmark-based and illustrative, to be validated against RxVantage's internal data in Phase 1. Full table with caveats in business-benchmarks.md.
Review platforms sharing the Gartner Digital Markets pool (Capterra/Software Advice/GetApp) were de-duplicated where identifiable. Practice-side reviews skew 2019–2021 (a review-collection campaign is evident); rep-side negatives skew 2023–2025, post-monetization changes, recency favors the rep-side signal. Reddit was inaccessible to research crawlers; we recommend a manual pass (r/sales, r/PharmaceuticalRep, r/MedicalDevices) in Phase 1. Reported pricing ($75→$99→$150→$195/mo) is user-reported and third-party-listed; RxVantage publishes no pricing page, confirm internally. Internal analytics (churn, funnel, support logs) were not available for this pre-work and are the first request of Phase 1.
Full research dossiers with verbatim quotes and ~80 source URLs accompany this deck: voc-findings.md · ecosystem-findings.md · synthesis-jtbd-strategy.md